ArticleCancer gene therapy2011

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.

J D Predina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.